New NHS Tests Offer Hope for Faster Endometriosis Diagnosis

Millions of women across England and Wales may soon face shorter waits for an endometriosis diagnosis, thanks to new guidance from the National Institute for Health and Care Excellence (NICE). The health body has approved two new tests, known as Endotest and Endosure, to be used within the NHS. These tools are designed to help doctors identify the condition much earlier, potentially ending the long and difficult journey that many patients currently face.

Endometriosis is a condition where tissue similar to the lining of the womb grows in other parts of the body, such as the ovaries. It affects one in 10 women of reproductive age and causes symptoms like severe pelvic pain, heavy periods, and fatigue. According to the BBC and The Guardian, the average time to receive a diagnosis in the UK is currently over nine years. This delay often leads to years of unnecessary suffering, as patients are frequently told their pain is caused by other issues, such as irritable bowel syndrome.

For many, the current diagnostic process is both slow and invasive. Traditionally, the main way to confirm the disease is through a laparoscopy—a surgical procedure where a camera is inserted into the stomach under general anaesthetic. The new tests offer a different approach. Endotest is a saliva test that looks for specific genetic material to indicate the presence of the disease. Meanwhile, Endosure uses sensor pads placed on the abdomen to measure electrical signals in the gut. During this 45-minute test, patients drink water to help the device record activity accurately.

Dr. Anastasia Chalkidou, a director at NICE, noted that these technologies have the potential to change lives. She explained that the current long delays contribute to chronic pain, which impacts daily work, relationships, and mental health. By providing primary care doctors with better tools, the NHS hopes to ensure that patients receive the right treatment much faster than before. Dr. Gail Busby, a consultant gynaecologist, described the tests as a "gamechanger" because they provide answers without the need for immediate surgery.

While these tests are a significant step forward, experts emphasize that they are not meant to be used alone. They are intended for patients who have already had a clinical exam and inconclusive imaging results. Furthermore, not every GP will have immediate access to these tools. The NHS plans to gather more evidence over the next three years to see how well the tests work in real-world settings before deciding on permanent, wider use. Emma Cox, chief executive of the charity Endometriosis UK, welcomed the news but stressed that the availability of these tests must be paired with better training for GPs and nurses to ensure they are used effectively.

Beyond these two tests, research continues into other ways to simplify diagnosis. For example, a team from the University of Edinburgh recently suggested that a blood test measuring hormone differences could also help identify the condition. Their study found that women with endometriosis often have a distinct "hormone fingerprint," including different levels of androgens, which are hormones often associated with males. While this research is still in the early stages and requires testing on a larger group of people, it highlights a growing focus on finding non-surgical solutions.

For patients like Ami Robertson, who experienced symptoms from the age of 16 but was not diagnosed for years, these developments come as a relief. She shared that she often doubted herself, wondering if the pain was "all in her head." Similarly, Sharan Uppal, who spent years seeking help for her daughter, believes that better testing would have opened doors to the care they desperately needed much sooner. As the NHS begins this new phase, the goal remains clear: to ensure that no one has to wait years to be believed or to receive the medical support they deserve.